GlassScriptPhysician profile
Jared K Littlejohn
NPI 1013440171
$9,194.58
in general payments reported to CMS, 2019-2025
26 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $167 · 2021: $622 · 2022: $4,519 · 2023: $2,144 · 2024: $543 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028 · Travel and Lodging: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,028.34 |
| Travel and Lodging | $1,734.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $4,339.41 | 2021-2025 | |
| Gotham Surgical Solutions & Devices, INC. | $1,442.85 | 2022 | |
| Arthrex, INC. | $1,244.00 | 2022 | |
| Stryker Corporation | $417.54 | 2025 | Prostep Mica, Citrefix |
| Depuy Synthes Sales INC. | $233.41 | 2022-2025 | Monovisc |
| Smith+Nephew, INC. | $227.30 | 2020-2022 | |
| Paragon 28, INC. | $154.19 | 2022-2024 | Precision Mis Bunion |
| Bioventus LLC | $131.50 | 2024-2025 | Durolane, Supartz Fx Sodium Hyaluronate, Gelsyn-3 |
| Paratek Pharmaceuticals, INC. | $124.99 | 2025 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.72 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $101.56 | 2021 | |
| Nevro Corp. | $82.83 | 2021-2023 | Senza |
| Pacira Pharmaceuticals Incorporated | $81.25 | 2023-2024 | Zilretta, Iovera, Exparel |
| Zimmer Biomet Holdings, INC. | $78.60 | 2023-2025 | Tapestry |
| Curonix LLC | $60.48 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $57.70 | 2021 | |
| Ethicon US, LLC | $52.30 | 2021-2025 | Surgicel Nu-Knit, Stratafix |
| Horizon Therapeutics Plc | $39.50 | 2020-2021 | |
| Linkbio Corp | $36.48 | 2025 | |
| Axogen | $34.06 | 2021 | |
| Fidia Pharma USA INC. | $27.36 | 2024 | Triluron |
| Endo Pharmaceuticals INC. | $26.78 | 2020-2022 | |
| Sanara Medtech INC. | $24.39 | 2022 | |
| Ibsa Pharma INC. | $23.53 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.94 | 2023 | Seglentis |
| Zimvie INC. | $12.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Littlejohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.